Becton Dickinson Value Stock - Dividend - Research Selection
Market price: 246,28 USD
Becton Dickinson Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||4.647.000.000|
|Free cash flow||3.416.000.000|
|Liabilities & Shareholders equity||53.866.000.000|
|Diluted shares outstanding||293.547.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||72.294.752.256,00 USD|
|Indices||MSCI World Index,S&P 500|
|Sectors||Health Care Equipment|
|Raw Data Source||US GAAP in Millionen USD|
|Stock Split||2022-04-01,1025.000000/1000.000000; 1998-08-22,2.0000/1.0000; 1998-08-21,2.0000/1.0000; 1996-08-17,2.0000/1.0000; 1996-08-16,2.0000/1.0000; 1993-03-02,2.0000/1.0000; 1993-03-01,2.0000/1.0000; 1986-03-04,2.0000/1.0000; 1986-03-03,2.0000/1.0000|
Description of the company
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.